SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-165305
Filing Date
2023-06-12
Accepted
2023-06-12 16:15:54
Documents
13
Period of Report
2023-06-06
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d451080d8k.htm   iXBRL 8-K 53041
2 EX-3.1 d451080dex31.htm EX-3.1 4905
  Complete submission text file 0001193125-23-165305.txt   184532

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tcrt-20230606.xsd EX-101.SCH 2839
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrt-20230606_lab.xml EX-101.LAB 17981
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrt-20230606_pre.xml EX-101.PRE 11251
7 EXTRACTED XBRL INSTANCE DOCUMENT d451080d8k_htm.xml XML 3436
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33038 | Film No.: 231008260
SIC: 2834 Pharmaceutical Preparations